ArticleFrontiers in oncology2020

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.

Hanna Engqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.